— Know what they know.
Not Investment Advice

AGPU NASDAQ

Axe Compute Inc.
1W: +6.0% 1M: -27.6% 3M: +25.4% YTD: +24.1% 1Y: +9.9% 3Y: -82.4% 5Y: -97.7%
$8.98
+0.99 (+12.39%)
 
Weekly Expected Move ±14.0%
$6 $7 $8 $9 $10
NASDAQ · Technology · Software - Infrastructure · Tech Score Sell · Power 29 · $102.2M mcap · 8M float · 4.65% daily turnover · Short 62% of daily vol
Credit Risk of going bust: higher than 83% of companies Debt: 1.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.8%), Axe Compute Inc. would be worth roughly what it owes.
Total debt $1.7M against a stock market value of $102.2M.
Distance to default 2.35 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $414K (short-term plus half of long-term), stock volatility 173.4%; Altman Z'' -28.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

11 relationships
11
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-12-01
Earliest Filing
2025-07-08
Latest Filing
target: 4 acquirer: 3 partner: 3 investor: 1

Counterparties (Filed by AGPU)

11 relationships

Companies named in AGPU's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
YA II PN, LTD. — investor Investor in the Standby Equity Purchase Agreement 2025-07-08 View
PREDICTIVE ONCOLOGY INC. POAI target Company issuing shares to the Investor 2025-07-08 View
Predictive Oncology Inc. — target Seller of assets related to automated medical fluid disposal business 2025-03-20 View
DeRoyal Industries, Inc. — acquirer Buyer acquiring assets related to automated medical fluid disposal business 2025-03-20 View
Predictive Oncology, Inc. — partner Party to extension agreement regarding merger transaction 2025-03-05 View
Renovaro, Inc. — partner Party to extension agreement regarding merger transaction 2025-03-05 View
Predictive Oncology Inc. — target Target company in proposed acquisition 2025-01-06 View
Renovaro Inc. — acquirer Acquiring entity in proposed stock purchase 2025-01-06 View
zPredicta, Inc. — target Target company in the merger agreement 2021-12-01 View
Golden Gate Acquisition Inc. — acquirer Acquiring parent company in the merger agreement 2021-12-01 View
Predictive Oncology Inc. — partner Parent company of the acquiring subsidiary 2021-12-01 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-05 Material Agreement; Regulation FD; Exhibits Agreement View
2026-09-17 Material Agreement; Acquisition/Disposition; Exhibits Agreement Acquisition View
2026-08-17 Other Events; Exhibits View
2026-08-14 Earnings Release; Exhibits View
2026-07-27 Other Events; Exhibits View
2026-07-22 Other Events; Exhibits View
2026-06-09 Other Events; Exhibits View
2026-05-18 Earnings Release; Exhibits View
2026-05-15 Other Events; Exhibits View
2026-05-12 Regulation FD; Exhibits View
2026-04-22 Other Events; Exhibits View
2026-04-16 Officer/Director Change; Exhibits View
2026-04-01 Officer/Director Change; Other Events; Exhibits View
2026-03-31 Earnings Release; Exhibits View
2026-03-09 Departure/Election of Directors; Appointment of Officers View
2026-02-09 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2026-01-22 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-12-12 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-12-11 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2025-12-02 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms